IBS-C Drug Market Report

China IBS-C Drug Industry Market Research Report 2023-2029

  • POSTDATE：Aug 29, 2023
  • PAGES：136
  • REPORT CODE：GMM1765799
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the IBS-C Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Trulance (Synergy Pharmaceuticals Inc)

    • Ironwood Pharmaceuticals

    • Ardelyx

    • Allergan

    • AMITIZA® (Sucampo Pharmaceuticals)

    • Takeda

    By Type:

    • Stimulant Laxatives

    • Linaclotide

    • Osmotic Laxatives

    • Lubiprostone

    • Others

    By Application:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China IBS-C Drug Market Overview 2018-2029

    • 1.1 China IBS-C Drug Industry Development Overview

    • 1.2 China IBS-C Drug Industry Development History

    • 1.3 China IBS-C Drug Industry Market Size (2018-2029)

    • 1.4 China IBS-C Drug Market Analysis by Type from Production Side

      • 1.4.1 China IBS-C Drug Production Volume, Production Value and Growth Rate of Stimulant Laxatives (2018-2029)

      • 1.4.2 China IBS-C Drug Production Volume, Production Value and Growth Rate of Linaclotide (2018-2029)

      • 1.4.3 China IBS-C Drug Production Volume, Production Value and Growth Rate of Osmotic Laxatives (2018-2029)

      • 1.4.4 China IBS-C Drug Production Volume, Production Value and Growth Rate of Lubiprostone (2018-2029)

      • 1.4.5 China IBS-C Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China IBS-C Drug Market Analysis by Application from Consumption End

      • 1.5.1 China IBS-C Drug Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

      • 1.5.2 China IBS-C Drug Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

      • 1.5.3 China IBS-C Drug Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

    • 1.6 China IBS-C Drug Market Analysis by Region

      • 1.6.1 North China IBS-C Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China IBS-C Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China IBS-C Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China IBS-C Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China IBS-C Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China IBS-C Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China IBS-C Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China IBS-C Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on IBS-C Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China IBS-C Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China IBS-C Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China IBS-C Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on IBS-C Drug Industry Development

    Chapter 3 IBS-C DrugIndustry Chain Analysis

    • 3.1 IBS-C Drug Industry Chain

    • 3.2 IBS-C Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the IBS-C Drug Market

    • 3.3 IBS-C Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the IBS-C Drug Market

    Chapter 4 China IBS-C Drug Market, by Type

    • 4.1 China IBS-C Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China IBS-C Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China IBS-C Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China IBS-C Drug Production Volume and Growth Rate of Stimulant Laxatives

      • 4.5.2 China IBS-C Drug Production Volume and Growth Rate of Linaclotide

      • 4.5.3 China IBS-C Drug Production Volume and Growth Rate of Osmotic Laxatives

      • 4.5.4 China IBS-C Drug Production Volume and Growth Rate of Lubiprostone

      • 4.5.5 China IBS-C Drug Production Volume and Growth Rate of Others

    Chapter 5 China IBS-C Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China IBS-C Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China IBS-C Drug Market Size and Growth Rate, by Application

      • 5.5.1 China IBS-C Drug Market Size and Growth Rate of Hospital Pharmacies

      • 5.5.2 China IBS-C Drug Market Size and Growth Rate of Retail Pharmacies

      • 5.5.3 China IBS-C Drug Market Size and Growth Rate of Online Pharmacies

    Chapter 6 China IBS-C Drug Market, by Region

    • 6.1 China IBS-C Drug Production Volume and Production Value, by Region

    • 6.2 China IBS-C Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China IBS-C Drug Market Analysis

    • 7.1 North China IBS-C Drug Market, by Type

    • 7.2 North China IBS-C Drug Market, by Application

    Chapter 8 Central China IBS-C Drug Market Analysis

    • 8.1 Central China IBS-C Drug Market, by Type

    • 8.2 Central China IBS-C Drug Market, by Application

    Chapter 9 South China IBS-C Drug Market Analysis

    • 9.1 South China IBS-C Drug Market, by Type

    • 9.2 South China IBS-C Drug Market, by Application

    Chapter 10 East China IBS-C Drug Market Analysis

    • 10.1 East China IBS-C Drug Market, by Type

    • 10.2 East China IBS-C Drug Market, by Application

    Chapter 11 Northeast China IBS-C Drug Market Analysis

    • 11.1 Northeast China IBS-C Drug Market, by Type

    • 11.2 Northeast China IBS-C Drug Market, by Application

    Chapter 12 Southwest China IBS-C Drug Market Analysis

    • 12.1 Southwest China IBS-C Drug Market, by Type

    • 12.2 Southwest China IBS-C Drug Market, by Application

    Chapter 13 Northwest China IBS-C Drug Market Analysis

    • 13.1 Northwest China IBS-C Drug Market, by Type

    • 13.2 Northwest China IBS-C Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Trulance (Synergy Pharmaceuticals Inc)

        • 14.1.1 Trulance (Synergy Pharmaceuticals Inc) Company Profile

        • 14.1.2 Trulance (Synergy Pharmaceuticals Inc) IBS-C Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Ironwood Pharmaceuticals

        • 14.2.1 Ironwood Pharmaceuticals Company Profile

        • 14.2.2 Ironwood Pharmaceuticals IBS-C Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Ardelyx

        • 14.3.1 Ardelyx Company Profile

        • 14.3.2 Ardelyx IBS-C Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Allergan

        • 14.4.1 Allergan Company Profile

        • 14.4.2 Allergan IBS-C Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 AMITIZA® (Sucampo Pharmaceuticals)

        • 14.5.1 AMITIZA® (Sucampo Pharmaceuticals) Company Profile

        • 14.5.2 AMITIZA® (Sucampo Pharmaceuticals) IBS-C Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Takeda

        • 14.6.1 Takeda Company Profile

        • 14.6.2 Takeda IBS-C Drug Market Performance

        • 14.6.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 IBS-C Drug Industry Research Conclusions

    • 15.2 IBS-C Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China IBS-C Drug Industry Market Size (2018-2029)

    • Figure China IBS-C Drug Production Volume, Production Value and Growth Rate of Stimulant Laxatives (2018-2029)

    • Figure China IBS-C Drug Production Volume, Production Value and Growth Rate of Linaclotide (2018-2029)

    • Figure China IBS-C Drug Production Volume, Production Value and Growth Rate of Osmotic Laxatives (2018-2029)

    • Figure China IBS-C Drug Production Volume, Production Value and Growth Rate of Lubiprostone (2018-2029)

    • Figure China IBS-C Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China IBS-C Drug Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • Figure China IBS-C Drug Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • Figure China IBS-C Drug Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

    • Figure North China IBS-C Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China IBS-C Drug Market Size and Growth Rate from 2018-2029

    • Figure South China IBS-C Drug Market Size and Growth Rate from 2018-2029

    • Figure East China IBS-C Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China IBS-C Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China IBS-C Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China IBS-C Drug Market Size and Growth Rate from 2018-2029

    • Figure IBS-C Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China IBS-C Drug Market Share by Type in 2018

    • Figure China IBS-C Drug Market Share by Type in 2023

    • Figure China IBS-C Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China IBS-C Drug Production Volume and Growth Rate of Stimulant Laxatives (2018-2023)

    • Figure China IBS-C Drug Production Volume and Growth Rate of Linaclotide (2018-2023)

    • Figure China IBS-C Drug Production Volume and Growth Rate of Osmotic Laxatives (2018-2023)

    • Figure China IBS-C Drug Production Volume and Growth Rate of Lubiprostone (2018-2023)

    • Figure China IBS-C Drug Production Volume and Growth Rate of Others (2018-2023)

    • Figure China IBS-C Drug Market Share by Application in 2018

    • Figure China IBS-C Drug Market Share by Application in 2023

    • Figure China IBS-C Drug Total Market Size and Growth Rate from Consumption End

    • Figure China IBS-C Drug Market Size and Growth Rate of Hospital Pharmacies (2018-2023)

    • Figure China IBS-C Drug Market Size and Growth Rate of Retail Pharmacies (2018-2023)

    • Figure China IBS-C Drug Market Size and Growth Rate of Online Pharmacies (2018-2023)

    • Table China IBS-C Drug Production Volume by Region (2018-2023)

    • Table China IBS-C Drug Production Volume Share by Region (2018-2023)

    • Figure China IBS-C Drug Production Volume Share by Region (2018-2023)

    • Table China IBS-C Drug Production Value by Region (2018-2023)

    • Table China IBS-C Drug Production Value Share by Region (2018-2023)

    • Figure China IBS-C Drug Production Value Share by Region (2018-2023)

    • Table China IBS-C Drug Sales Volume by Region (2018-2023)

    • Table China IBS-C Drug Sales Volume Share by Region (2018-2023)

    • Figure China IBS-C Drug Sales Volume Share by Region (2018-2023)

    • Table China IBS-C Drug Sales Value by Region (2018-2023)

    • Table China IBS-C Drug Sales Value Share by Region (2018-2023)

    • Figure China IBS-C Drug Sales Value Share by Region (2018-2023)

    • Table North China IBS-C Drug Production Volume by Type (2018-2023)

    • Table North China IBS-C Drug Production Volume Share by Type (2018-2023)

    • Figure North China IBS-C Drug Production Volume Share by Type (2018-2023)

    • Table North China IBS-C Drug Sales Volume by Application (2018-2023)

    • Table North China IBS-C Drug Sales Volume Share by Application (2018-2023)

    • Figure North China IBS-C Drug Sales Volume Share by Application (2018-2023)

    • Table Central China IBS-C Drug Production Volume by Type (2018-2023)

    • Table Central China IBS-C Drug Production Volume Share by Type (2018-2023)

    • Figure Central China IBS-C Drug Production Volume Share by Type (2018-2023)

    • Table Central China IBS-C Drug Sales Volume by Application (2018-2023)

    • Table Central China IBS-C Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China IBS-C Drug Sales Volume Share by Application (2018-2023)

    • Table South China IBS-C Drug Production Volume by Type (2018-2023)

    • Table South China IBS-C Drug Production Volume Share by Type (2018-2023)

    • Figure South China IBS-C Drug Production Volume Share by Type (2018-2023)

    • Table South China IBS-C Drug Sales Volume by Application (2018-2023)

    • Table South China IBS-C Drug Sales Volume Share by Application (2018-2023)

    • Figure South China IBS-C Drug Sales Volume Share by Application (2018-2023)

    • Table East China IBS-C Drug Production Volume by Type (2018-2023)

    • Table East China IBS-C Drug Production Volume Share by Type (2018-2023)

    • Figure East China IBS-C Drug Production Volume Share by Type (2018-2023)

    • Table East China IBS-C Drug Sales Volume by Application (2018-2023)

    • Table East China IBS-C Drug Sales Volume Share by Application (2018-2023)

    • Figure East China IBS-C Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China IBS-C Drug Production Volume by Type (2018-2023)

    • Table Northeast China IBS-C Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China IBS-C Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China IBS-C Drug Sales Volume by Application (2018-2023)

    • Table Northeast China IBS-C Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China IBS-C Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China IBS-C Drug Production Volume by Type (2018-2023)

    • Table Southwest China IBS-C Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China IBS-C Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China IBS-C Drug Sales Volume by Application (2018-2023)

    • Table Southwest China IBS-C Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China IBS-C Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China IBS-C Drug Production Volume by Type (2018-2023)

    • Table Northwest China IBS-C Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China IBS-C Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China IBS-C Drug Sales Volume by Application (2018-2023)

    • Table Northwest China IBS-C Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China IBS-C Drug Sales Volume Share by Application (2018-2023)

    • Table Trulance (Synergy Pharmaceuticals Inc) Company Profile

    • Table Trulance (Synergy Pharmaceuticals Inc) IBS-C Drug Revenue, Price and Gross (2018-2023)

    • Table Ironwood Pharmaceuticals Company Profile

    • Table Ironwood Pharmaceuticals IBS-C Drug Revenue, Price and Gross (2018-2023)

    • Table Ardelyx Company Profile

    • Table Ardelyx IBS-C Drug Revenue, Price and Gross (2018-2023)

    • Table Allergan Company Profile

    • Table Allergan IBS-C Drug Revenue, Price and Gross (2018-2023)

    • Table AMITIZA® (Sucampo Pharmaceuticals) Company Profile

    • Table AMITIZA® (Sucampo Pharmaceuticals) IBS-C Drug Revenue, Price and Gross (2018-2023)

    • Table Takeda Company Profile

    • Table Takeda IBS-C Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US